On with Kara Swisher Why Reed Jobs is Betting on Cancer Innovations
17 snips
Mar 7, 2024 Reed Jobs, founder of Yosemite and son of Steve Jobs, shares his deep commitment to making cancer non-lethal, a mission influenced by his father's battle with the disease. He discusses innovative investment strategies in cancer treatment, emphasizing collaboration between philanthropy and biotechnology. Reed highlights the potential of AI, mRNA, and CRISPR in revolutionizing patient care and the critical need for early detection. His personal journey underscores the emotional stakes driving his work in advancing cancer research and the urgent realities faced today.
AI Snips
Chapters
Transcript
Episode notes
Non-Lethal Cancer
- Reed Jobs aims to make cancer non-lethal, not to cure it, focusing on reducing mortality.
- He believes cancer, like cardiovascular disease, will eventually be managed through monitoring and early intervention.
From Grants to VC
- Reed Jobs's family office, Emerson Collective, initially funded cancer research through grants.
- Dissatisfied with the lack of transparency and patient impact, he shifted to a venture capital model.
Life Sciences vs. Tech Founders
- Unlike tech, life sciences founders (academics) rarely become CEOs.
- Management and scientific work are often separate, requiring a different approach to venture capital.